Abstract
The September 11, 2001 events in New York City and Washington D.C. abruptly changed our perspectives about the likelihood that terrorists could direct weapons of mass destruction against civilian communities in the United States. On October 4, 2001, the Centers for Disease Control and Prevention (CDC) and their state and local partners reported a case of inhalational anthrax in Florida.1 Over the following several weeks, public health authorities reported additional cases from Florida and New York City. Investigations revealed that the intentional release of Bacillus anthracis was responsible for these cases.2 By November 9, 22 cases (17 confirmed and 5 suspected) of bioterrorism-related anthrax were reported from Washington D.C., Florida, New Jersey and New York City.3 Ten of these cases were the inhalational form, resulting in 4 deaths; the other 12 cases were cutaneous anthrax. Of the 10 inhalation cases, most were people who had processed, handled, or received letters containing B. anthracis spores.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Centers for Disease Control and Prevention. Ongoing investigation of anthrax—Florida, October 2001. Morbidity and Mortality Weekly Report 50. 2001; 40: 877.
Centers for Disease Control and Prevention. Update: Investigation of anthrax associated with intentional exposure and interim public health guidelines. Morbidity and Mortality Weekly Report 50, 2001; 41: 889–93.
Centers for Disease Control and Prevention. Update: Investigation of bioterrorismrelated anthrax and adverse events from antimicrobial prophylaxis. Morbidity and Mortality Weekly Report 50. 2001; 44: 973–6.
Centers for Disease Control and Prevention. Update: Investigation of bioterrorismrelated anthrax and interim guidelines for clinical evaluation of persons with possible anthrax. Morbidity and Mortality Weekly Report 50. 2001; 43: 941–8.
Centers for Disease Control and Prevention. Biological and chemical terrorism: Strategic plan for preparedness and response. Recommendations of the CDC Strategic Planning Workgroup. Morbidity and Mortality Weekly Report 49, no. RRO4 (April 21, 2000 ): 1–14
Centers for Disease Control and Prevention. Recognition of illness associated with the intentional release of a biologic agent. Morbidity and Mortality Weekly Report 50. 2001; 41: 893–7.
Inglesby TV, Henderson DA, Bartlett JG, et al. Anthrax as a biological weapon. Medical and public health management. JAMA 1999:281(18):1735–45. Also available at http://www.bt.cdc.gov (last accessed 11/3/2001).
Centers for Disease Control and Prevention. Notice to readers: Considerations for distinguishing influenza-like illness from inhalational anthrax. Morbidity and Mortality Weekly Report 50. 2001; 44: 984–6.
Centers for Disease Control and Prevention Update: Investigation of bioterrorism-re-lated anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. Morbidity and Mortality Weekly Report 50, 2001; 42: 909–19.
Dixon TC, Meselson M, Guillemin J. Anthrax. N Engl J Med 1999; 341: 815–26.
Centers for Disease Control and Prevention. Notice to Readers: Interim guidelines for investigation of and response to Bacillus anthracis exposures. Morbidity and Mortality Weekly Report 50. 2001; 44 987–90.
Inglesby TV, Dennis DT, Henderson DA, et al. Plague as a biological weapon: Medical and public health management. JAMA 2000;283:2281–90. Also available at http://www.bt.cdc.gov (last accessed 11/3/2001)
Henning KJ, Layton M. Bioterrorism. In APIC Text of Infection Control and Epidemiology. Association of Professionals in Infection Control and Epidemiology Inc. Washington, D.C. (2000): Chapter 24: 1–11.
Henderson DA, Inglesby TV, Bartlett JG, et al. Smallpox as a biological weapon: Medical and public health management. JAMA 1999;281:2127–37. Also available at http://www.bt.cdc.gov (last accessed 11/3/2001)
Arnon SS, Schechter R, Inglesby TV, et al. Botulinum toxin as a biological weapon: Medical and public health management. JAMA 2001:285:1059–70. Also available at http://www.bt.cdc.gov (last accessed 11/3/2001)
Dennis DT, Inglesby TV, Henderson DA, et al. Tularemia as a biological weapon: Medical and public health management. JAMA 2001;285:2763–73. Also available at http://www.bt.cdc.gov (last accessed 11/3/2001
Centers for Disease Control and Prevention. Viral hemorrhagic fevers: Fact sheets. http://www.cdc.gov/ncidod/dvrd/spb/mnpages/factmenu.htm. Last accessed 11/14/01.
Nerve Agents. Agency for Toxic Substances and Disease Registry. http://www.bt.cdc. gov/agent/nerve/Nervesfnl.pdf. Last accessed 11–14–01.
Blister Agents. Agency for Toxic Substances and Disease Registry. Nitrogen Mustard (HN–1) (C6H13C12N) CAS 538–07–8, UN 2810; Nitrogen Mustard (HN–2) (C5H11C12N) CAS 51–75–2, UN 2927;andNitrogen Mustard (HN–3) (C6H12C13N) CAS 555–77–1, UN 2810. http://www.bt.cdc.gov/Agent/Blister/NMUSTARDfnl.pdf. Last accessed 11–14–01.
Blister Agents. Lewisite (L) (C2H2AsC13) CAS 541–25–3, UN 1556; and Mustard–Lewisite Mixture (HL) CAS Number not available, UN 2810 Agency for Toxic Substances and Disease Registry. http://www.bt.cdc.gov:80/Agent/Blister/Lewisitefnl. pdf. Last accessed 11–14–01.
Lange JT, Lange CL, Cabaltica RBG. Primary care treatment of post-traumatic stress disorder. American Family Physician 2000; 62 (5): 1035–1040.
Saultz, JS. Textbook of Family Medicine. New York: McGraw-Hill. 2000.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Melnick, A.L. (2003). The Family Physician’s Role in Responding to Biological and Chemical Terrorism. In: Taylor, R.B., David, A.K., Fields, S.A., Phillips, D.M., Scherger, J.E. (eds) Fundamentals of Family Medicine. Springer, New York, NY. https://doi.org/10.1007/978-0-387-21745-1_27
Download citation
DOI: https://doi.org/10.1007/978-0-387-21745-1_27
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-95479-0
Online ISBN: 978-0-387-21745-1
eBook Packages: Springer Book Archive